{"id":2,"date":"2022-11-11T15:20:09","date_gmt":"2022-11-11T19:20:09","guid":{"rendered":"https:\/\/knighttx.com\/?page_id=2"},"modified":"2026-10-20T09:51:11","modified_gmt":"2026-10-20T13:51:11","slug":"home","status":"publish","type":"page","link":"https:\/\/knighttx.com\/fr\/","title":{"rendered":"Home"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2\" class=\"elementor elementor-2\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-ca4b2e0 elementor-section-height-min-height elementor-section-items-top elementor-section-content-top elementor-section-boxed elementor-section-height-default\" data-id=\"ca4b2e0\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-no\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-33 elementor-top-column elementor-element elementor-element-a6163bf\" data-id=\"a6163bf\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a78d3ad elementor-invisible elementor-widget elementor-widget-heading\" data-id=\"a78d3ad\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeIn&quot;,&quot;_animation_delay&quot;:0}\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l'Am\u00e9rique latine<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-66 elementor-top-column elementor-element elementor-element-a8aebd4\" data-id=\"a8aebd4\" data-element_type=\"column\" data-e-type=\"column\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3eea0e8 elementor-invisible elementor-widget elementor-widget-image\" data-id=\"3eea0e8\" data-element_type=\"widget\" data-e-type=\"widget\" data-settings=\"{&quot;_animation&quot;:&quot;fadeInRight&quot;}\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/knighttx.com\/images-global\/banner-topo2024.png\" title=\"\" alt=\"\" loading=\"lazy\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-e030ab5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"e030ab5\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-cdc69ce\" data-id=\"cdc69ce\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3faf153 elementor-widget elementor-widget-heading\" data-id=\"3faf153\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h5 class=\"elementor-heading-title elementor-size-default\">Nouvelles<\/h5>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-0c32cf1 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"0c32cf1\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-933cfa5\" data-id=\"933cfa5\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8cad5bc elementor-widget elementor-widget-text-editor\" data-id=\"8cad5bc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"list-item-details-container-3375375\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><div id=\"list-item-details-container-3375375\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><span id=\"list-item-content-date-3375375\" class=\"list-item-content-date\">October 06, 2026 07:35 ET<\/span><\/div><span class=\"source-section\"><label class=\"source-separator mr-1\">|<\/label><label class=\"label-source\">Source:<\/label><a class=\"organization-name\" href=\"https:\/\/www.globenewswire.com\/en\/search\/organization\/Knight%2520Therapeutics\" data-autid=\"organization-name\">Th\u00e9rapeutique Knight inc.<\/a><\/span><\/div><a id=\"list-item-content-title-3375375\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375375\/0\/fr\/th%C3%A9rapeutique-knight-annonce-l-approbation-r%C3%A9glementaire-de-niktimvo-au-br%C3%A9sil.html\" target=\"_self\">Th\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de NIKTIMVO\u00ae au Br\u00e9sil<\/a><div id=\"list-item-content-body-3375375\" class=\"list-item-content-body\">MONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui avoir re\u00e7u une&#8230;<\/div><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a2d125b elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"a2d125b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9798935 elementor-widget elementor-widget-text-editor\" data-id=\"9798935\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div id=\"list-item-details-container-3375365\" class=\"list-item-details-container\"><div class=\"list-item-details-reading-date\"><span id=\"list-item-content-date-3375365\" class=\"list-item-content-date\">October 06, 2026 07:30 ET<\/span><\/div><span class=\"source-section\"><label class=\"source-separator mr-1\">|<\/label><label class=\"label-source\">Source:<\/label><a class=\"organization-name\" href=\"https:\/\/www.globenewswire.com\/en\/search\/organization\/Knight%2520Therapeutics\" data-autid=\"organization-name\">Th\u00e9rapeutique Knight inc.<\/a><\/span><\/div><p><a id=\"list-item-content-title-3375365\" class=\"list-item-content-title\" href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/06\/3375365\/0\/fr\/th%C3%A9rapeutique-knight-annonce-le-lancement-de-tavalisse-au-br%C3%A9sil.html\" target=\"_self\">Th\u00e9rapeutique Knight annonce le lancement de TAVALISSE\u00ae au Br\u00e9sil<\/a><\/p><div id=\"list-item-content-body-3375365\" class=\"list-item-content-body\">MONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui le lancement de&#8230;<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-509051c elementor-widget-divider--view-line elementor-widget elementor-widget-divider\" data-id=\"509051c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"divider.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-divider\">\n\t\t\t<span class=\"elementor-divider-separator\">\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-02b1150 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"02b1150\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-62a36fa\" data-id=\"62a36fa\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c502bf4 elementor-widget elementor-widget-spacer\" data-id=\"c502bf4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0f1e01a elementor-widget elementor-widget-feedzy-rss-feeds\" data-id=\"0f1e01a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"feedzy-rss-feeds.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"feedzy-23ef3821ae62771df02a80085839c97f feedzy-rss\">\n\t\t<ul class=\"feedzy-default\">\n\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/11\/05\/3396184\/0\/fr\/th%C3%A9rapeutique-knight-d%C3%A9clare-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-de-l-exercice-2026.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tTh\u00e9rapeutique Knight d\u00e9clare ses r\u00e9sultats du troisi\u00e8me trimestre de l\u2019exercice 2026\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>Niveau record des produits des activit\u00e9s ordinaires de plus de 430 millions de dollars et du BAIIA ajust\u00e91 de plus de 76 millions de dollars pour la p\u00e9riode de neuf moisPr\u00e9visions relev\u00e9es pour 2026 : produits des activit\u00e9s ordinaires passant \u00e0 une fourchette de 560 millions de dollars \u00e0 570 millions de dollars et BAIIA ajust\u00e91 [&hellip;]<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t\t\t<li  style=\"padding: 15px 0 25px\" class=\"rss_item feedzy-rss-col-1\" >\n\t\t\t\t\t\t\t\t\t<span class=\"title\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.globenewswire.com\/news-release\/2026\/10\/29\/3391155\/0\/fr\/avis-de-conf%C3%A9rence-t%C3%A9l%C3%A9phonique-de-th%C3%A9rapeutique-knight-sur-ses-r%C3%A9sultats-du-troisi%C3%A8me-trimestre-2026.html\" target=\"_blank\"  rel=\"noopener nofollow\">\n\t\t\t\t\t\t\tAvis de conf\u00e9rence t\u00e9l\u00e9phonique de Th\u00e9rapeutique Knight sur ses r\u00e9sultats du troisi\u00e8me trimestre 2026\t\t\t\t\t\t<\/a>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<div class=\"rss_content\"\n\t\t\t\t\t\tstyle=\"\">\n\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<p>MONTR\u00c9AL,  29 oct. 2026  (GLOBE NEWSWIRE) -- Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab\u2009Knight\u2009\u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (ex. EU), publiera ses r\u00e9sultats financiers du troisi\u00e8me trimestre 2026, ce jeudi 5 novembre 2026 avant l\u2019ouverture du march\u00e9. \u00c0 la suite de cette publication, Knight sera l\u2019h\u00f4te d\u2019une [&hellip;]<\/p>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/li>\n\t\t\t\t<\/ul>\n<\/div>\n<style type=\"text\/css\" media=\"all\">.feedzy-rss .rss_item .rss_image{float:left;position:relative;border:none;text-decoration:none;max-width:100%}.feedzy-rss .rss_item .rss_image span{display:inline-block;position:absolute;width:100%;height:100%;background-position:50%;background-size:cover}.feedzy-rss .rss_item .rss_image{margin:.3em 1em 0 0;content-visibility:auto}.feedzy-rss ul{list-style:none}.feedzy-rss ul li{display:inline-block}<\/style>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-a69fb2d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"a69fb2d\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2a3201f\" data-id=\"2a3201f\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-95c9352 elementor-align-center elementor-hidden-tablet elementor-widget elementor-widget-button\" data-id=\"95c9352\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm elementor-animation-grow\" href=\"https:\/\/investors.knighttx.com\/French\/nouvelles\/default.aspx\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Voir plus <\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-b64ba3c elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b64ba3c\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-44d788c\" data-id=\"44d788c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c3d9146 elementor-widget elementor-widget-spacer\" data-id=\"c3d9146\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>B\u00e2tir une compagnie pharmaceutique chef de file pour le Canada et l&#8217;Am\u00e9rique latine Nouvelles October 06, 2026 07:35 ET|Source:Th\u00e9rapeutique Knight inc.Th\u00e9rapeutique Knight annonce l\u2019approbation r\u00e9glementaire de NIKTIMVO\u00ae au Br\u00e9silMONTR\u00c9AL, 06 oct. 2026 (GLOBE NEWSWIRE) &#8212; Th\u00e9rapeutique Knight inc. (TSX : GUD) (\u00ab Knight \u00bb), soci\u00e9t\u00e9 pharmaceutique panam\u00e9ricaine (hors \u00c9tats-Unis), a annonc\u00e9 aujourd\u2019hui avoir re\u00e7u une&#8230; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"footnotes":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":515,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"predecessor-version":[{"id":79733,"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/pages\/2\/revisions\/79733"}],"wp:attachment":[{"href":"https:\/\/knighttx.com\/fr\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}